Conmed Corp (FRA:EC8)
€ 64.5 0 (0%) Market Cap: 2.10 Bil Enterprise Value: 2.93 Bil PE Ratio: 17.58 PB Ratio: 2.45 GF Score: 70/100

Conmed Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 09:00PM GMT
Release Date Price: €103 (-0.96%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining us today for the 2021 Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analyst here. It's my pleasure today to have Curt Hartman, President and CEO; and Todd Garner, EVP and CFO of CONMED with us today. Just before we jump into our fireside chat, for important disclosures, please see morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. So Curt and Todd, thank you so much for being here today. Really appreciate the time.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

I don't think you'd be surprised with the topic to start. But just given that multiple companies have been talking about at this conference in the past week, the elective surgery impact from Delta, some have pointed to pressure adjusted numbers, but maybe at a high level, what are you seeing in terms of Delta across your orthopedics

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot